共 50 条
- [31] Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2019, 10 (02): : 52 - 61
- [32] First-line metastatic cancer of the colon [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (05): : B150 - B153
- [33] First-line Therapeutic Strategies, for Myelodysplastic Syndromes [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S31 - S36
- [34] Metastatic Colorectal Cancer: A Curable Disease THE BARTLETT/CHU ARTICLE REVIEWED [J]. ONCOLOGY-NEW YORK, 2012, 26 (03): : 275 - +
- [35] Metastatic colorectal cancer: Is there one standard approach? The Saltz article reviewed [J]. ONCOLOGY-NEW YORK, 2005, 19 (09): : 1158 - +
- [36] Metastatic Colorectal Cancer: Potential for Cure? THE BARTLETT/CHU ARTICLE REVIEWED [J]. ONCOLOGY-NEW YORK, 2012, 26 (03): : 284 - 285
- [38] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab [J]. ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82